Unfortunately, you expect too much. 42 cents monthend July would properly reflect the value of this quarterly report.
This report, together with the cash flow statement, shows how prudent management is in reporting what is actually happening, no bull and no ramping.
Take these:
- so much cash to complete the 2000 plant and see it through operations, even if we suffer teething problems which is expected of companies that are in startup operations more so in these Covid times. Even a delay of a few months will not hurt the company.
- it looks as though the interested chain partners to be are simply awaiting the 10k approval to finalise funding and offtake arrangements and there are so many competing to get our favour.
- the selling of the 2000 plant production at spot augers well for the company at todays' prices; the market is there eagerly awaiting startup.
- the risk we can't get 10k approval is so close to zero; it appears the commissioning of the 2k plant and its inauguration is what the Salta government is waiting for.
People who expect much at so short a time run the risk of panicking and selling then find themselves not able to get back. Will you be one of them?
- Forums
- ASX - By Stock
- AGY
- Ann: Quarterly Activities Report - June 2022
Ann: Quarterly Activities Report - June 2022, page-54
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
-0.004(4.71%) |
Mkt cap ! $120.8M |
Open | High | Low | Value | Volume |
8.5¢ | 8.5¢ | 8.1¢ | $83.04K | 994.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 67884 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 48368 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 67884 | 0.081 |
9 | 338890 | 0.080 |
5 | 230992 | 0.079 |
3 | 407778 | 0.078 |
4 | 39000 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 48368 | 5 |
0.083 | 254412 | 2 |
0.086 | 90000 | 1 |
0.087 | 100000 | 1 |
0.088 | 232558 | 1 |
Last trade - 11.37am 16/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online